Cook Incorporated
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$42Mgeneral payments (2019-2025)
$376Kresearch payments (2019-2025)
1,398clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
- Zenith Spiral-Z $5.0M associated (2023-2025)
- Ncircle $2.8M associated (2023-2025)
- Cook $1.1M associated (2023-2025)
- Performer $688K associated (2023-2025)
- Zilver Ptx $404K associated (2023-2025)
- Check-Flo $368K associated (2023-2025)
- Zenith Alpha $366K associated (2023-2025)
- Resonance $274K associated (2023-2025)
- Zilver Vena $253K associated (2023-2025)
- Zenith $230K associated (2023-2025)
- S~Curve $163K associated (2023-2025)
- Tornado $151K associated (2023-2025)
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Robert Lippitt | Smithfield, NC | Urology | $11,392,319.36 |
| Timothy Chuter | San Francisco, CA | Surgery | $8,805,414.24 |
| John Anderson | Bethlehem, PA | Urology | $2,124,728.92 |
| Gary Ansel | Columbus, OH | Interventional Cardiology | $2,097,801.14 |
| Samuel Giday | Orlando, FL | Gastroenterology (Internal Medicine) | $2,029,192.31 |
| Peter Balkin | Honolulu, HI | Diagnostic Radiology | $879,280.47 |
| David Armstrong | Lawrenceville, GA | Colon & Rectal Surgery | $677,679.83 |
| Neil Bander | New York, NY | Urology | $536,127.12 |
| Demetrius Bagley | Philadelphia, PA | Urology | $487,549.04 |
| Zahid Saeed | Crestview Hills, KY | Gastroenterology (Internal Medicine) | $411,070.04 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.